Gene therapy for disorders of the extracellular matrix — Douglas Gould (UNIVERSITY OF CALIFORNIA, SAN FRANCISCO)
PROJECT SUMMARY COL4A1 and COL4A2 mutations cause Gould syndrome (GS) – a multisystem disorder for which clinically heterogeneous cerebrovascular disease is the major consequence. Cerebrovascular dise
| Project title | Gene therapy for disorders of the extracellular matrix |
|---|---|
| Project number | 1RF1NS128217-01A1 |
| PI name | Douglas Gould |
| Institution | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
| Funding mechanism | RF1 |
| Agency | NINDS |
| Award amount | $2.48M |
| Fiscal year | 2023 |
| Project start | 2023-04-01T00:00:00 |
| Project end | 2026-03-31T00:00:00 |
| Abstract | PROJECT SUMMARY COL4A1 and COL4A2 mutations cause Gould syndrome (GS) – a multisystem disorder for which clinically heterogeneous cerebrovascular disease is the major consequence. Cerebrovascular dise |
| Key terms | <AAV vector><Ablation><Address><Affect><Alleles><Allelomorphs><Aminoacetic Acid><Antimorphic mutatio |
$799/mo
Try GrantRadar →